HomeLPGO • STO
add
Lipigon Pharmaceuticals AB
Previous close
kr 0.0086
Day range
kr 0.0078 - kr 0.0090
Year range
kr 0.0072 - kr 0.28
Market cap
4.97M SEK
Avg Volume
9.68M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.29M | 28.72% |
Net income | -7.41M | -10.17% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -7.45M | -16.12% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.60M | 54.59% |
Total assets | 18.08M | -14.01% |
Total liabilities | 2.99M | 17.01% |
Total equity | 15.09M | — |
Shares outstanding | 605.93M | — |
Price to book | 0.43 | — |
Return on assets | -83.66% | — |
Return on capital | -99.49% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -7.41M | -10.17% |
Cash from operations | -8.32M | 4.99% |
Cash from investing | -108.00K | — |
Cash from financing | 43.00K | 187.76% |
Net change in cash | -8.39M | 4.02% |
Free cash flow | -5.69M | 4.80% |
About
Founded
2010
Website
Employees
7
